As the leading cause of death for women in the United States, according to the Centers for Disease Control and Prevention, ...

An older woman with no prior cardiac or neurologic history developed unexplained syncope shortly after initiating acamprosate. The comprehensive diagnostic workup was unremarkable. Acamprosate was ...

Adam Christman, DVM, MBA: Okay, I think the number one most important question, not most important. There's a lot of great ones, but this is a very common question that we ask get asked is it a ...

Milsaperidone is an active metabolite of iloperidone ...

The Heart Center at Timpanogos Regional Hospital in Orem is now open to serve patients. The clinic offers cardiovascular ...

In February 2012, 15-year-old Kelsey Keefe was at church with her family and began to feel sick, her heart racing beneath her chest. Just minutes later, she fainted into her mother’s arms. After ...

Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal ...

Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS study PALYNZIQ is the ...

Bristol Myers Squibb today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo for anemia in ...

Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2025 financial results and provided a corporate update.

Timely recognition of symptoms like chest pain, breathlessness, syncope, palpitations, or sudden neurological deficits can ...